The leading coronavirus vaccines will need cold-chain equipment to maintain stability during distribution, but the US Centers for Disease Control and Prevention is not ready to advise potential vaccination points to purchase special freezers for product storage.
Pfizer Inc. and Moderna, Inc. both have mRNA vaccines that have been administered to thousands of patients in phase III trials